Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

The conclusion is that a new method can identify cosmetic residues on hair and match them to their products.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Different oils penetrate hair differently; monounsaturated oils like olive oil penetrate better than polyunsaturated oils.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The study found that certain conditioning compounds can penetrate hair and potentially improve its resistance to damage.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib may help treat hair loss in children with alopecia areata.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.